NCT06445569View on ClinicalTrials.gov

Safety and Efficacy of KH-1 for Stimulating Autophagy in Non-diabetic Adults With Elevated Blood Glucose Concentration

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

June 8, 2023

Study Completion Date

June 8, 2023

Conditions
PreDiabetesAging
Interventions
DIETARY_SUPPLEMENT

KH-1

3 capsules and one stick packet consumed daily around the same time

OTHER

Placebo

3 capsules and one stick packet consumed daily around the same time

Trial Locations (1)

38119

LifeDOC Research, PLLC, Memphis

Sponsors

Lead Sponsor

Kalin Health, LLC
All Listed Sponsors
collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

Kalin Health, LLC

INDUSTRY

NCT06445569 - Safety and Efficacy of KH-1 for Stimulating Autophagy in Non-diabetic Adults With Elevated Blood Glucose Concentration | Biotech Hunter | Biotech Hunter